News and Press Releases

Read Veristat news and press releases to learn about our CRO service growth, geographic expansion in Europe and Asia, biotechnology preferred partnerships and small CRO acquisitions.

Veristat to Assist on Adaptive Enrichment Design Trial for Verastem’s Defactinib in...

Input Will Drive Trial Design for Lead Cancer Stem Cell-Targeting Program

 

September 10, 2013  -  Veristat, a leading,...

Veristat’s Collaboration with Aegerion Contributes to FDA Approval of Juxtapid™

Veristat’s Strategic Guidance Contributes to Successful Approval of Aegerion’s Novel Drug Juxtapid

 

Variance Development Partners Makes a Growth Investment in Veristat

Investment Will Enable Veristat to Further Enhance its Market Leadership Position and Provide Resources for Growth

Veristat, a ...